Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 2/20 | 0.51 |
| ▸ | ELANE | P08246 | 2/20 | 0.51 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 2/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6640954 | 0.91 | CTRB1 (0.51) | CTRB1ELANE | |
| SCHEMBL6636916 | 0.89 | CTRB1 (0.50) | CTRB1ELANECYP17A1TAAR1CTSK | |
| SCHEMBL6641428 | 0.88 | CTRB1 (0.52) | CTRB1ELANE | |
| SCHEMBL6636920 | 0.86 | CTRB1 (0.52) | CTRB1ELANECYP17A1TAAR1CTSK | |
| SCHEMBL6637518 | 0.86 | CTRB1 (0.53) | CTRB1ELANECYP17A1 | |
| SCHEMBL6637653 | 0.85 | CTRB1 (0.51) | CTRB1ELANECYP17A1TAAR1CTSK | |
| SCHEMBL6637260 | 0.85 | CTRB1 (0.46) | CTRB1ELANECYP17A1PPARG | |
| SCHEMBL6636633 | 0.85 | CTRB1 (0.46) | CTRB1ELANECYP17A1CTSKP2RX7 | |
| SCHEMBL6636428 | 0.84 | ELANE (0.57) | CTRB1ELANECYP17A1 | |
| SCHEMBL6637590 | 0.84 | CTRB1 (0.49) | CTRB1ELANECYP17A1TAAR1CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1403269-A1 | REMEDIAL AGENT FOR VIRAL INFECTIOUS DISEASE | Asahi Kasei Pharma Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |